C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2001
10/24/2001	CN1319138A Pesticidal toxins and genes from i-bacillus laterosporus) strains
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway
10/24/2001	CN1319105A Methods for produsction of antibodies to specific regions of cyclosporine and cyclosporine metabolites
10/24/2001	CN1319019A i(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists
10/24/2001	CN1318974A Receptor-like protein kinase, RKN, and methods of use for increasing growth and yield in plants
10/24/2001	CN1318646A Coded salmonella typhi specific and antigenic outer membrane protein DNA sequence
10/24/2001	CN1318643A Equipment or equipment combination for autotransplantation of cell nucleus
10/24/2001	CN1073624C Vector for producing transgenic plant and its method
10/23/2001	US6307129 Herbicide tolerant plants, plant tissue or plant cells having altered protoporphyrinogen oxidase activity
10/23/2001	US6307127 Transformation of guar
10/23/2001	US6307126 Nucleic acid encoding GAI gene of Arabidopsis thaliana
10/23/2001	US6307125 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
10/23/2001	US6307124 Nucleic acid molecules encoding soluble starch synthases from maize
10/23/2001	US6307038 Nucleotide sequences coding fusion protein for use in treatment of oxidative stress
10/23/2001	US6307031 Beta taipoxin as a cell growth factor and method
10/23/2001	US6307027 Bradykinin B1 receptor antibodies
10/23/2001	US6307020 Skin freeze resistant protein; for use in food processing
10/23/2001	US6306922 Macromer polymers crosslinked by photopolymerization
10/23/2001	US6306833 Methods and compositions for inducing tumor-specific cytotoxicity
10/23/2001	US6306831 Transplacental delivery of oligonucleotides
10/23/2001	US6306821 Modified with biocompatible peptide, protein, glycoprotein, or carbohydrate; orthopedics; molecular weight control
10/23/2001	US6306654 Nucleotide sequence coding mutant gonadotrophin hormone; for treatment of reproduction defects
10/23/2001	US6306652 Packaging systems for human recombinant adenovirus to be used in gene therapy
10/23/2001	US6306651 Bone marrow hematopoietic stem cell; for use in prevention of graft versus host disease
10/23/2001	US6306650 Nucleic acid molecule encoding a β-erythroid krüppel-like factor that binds to a δ-globin promoter
10/23/2001	US6306646 Culture dish
10/23/2001	US6306644 Device for cultivating different mammal cells at the same time
10/23/2001	US6306628 Methods for the detection, analysis and isolation of Nascent proteins
10/23/2001	US6306624 Retinoid metabolizing protein
10/23/2001	US6306622 cDNA encoding a BMP type II receptor
10/23/2001	US6306618 Contacting sample with enzyme capable of degrading homocysteine, and determining any reaction product(s) formed
10/23/2001	US6306608 Anti-human LECT2 antibody, cells producing the same, and method and kit for assaying the same
10/23/2001	US6306605 Methods for making recombinant cells
10/23/2001	US6306588 Polymerase with mutation in o-helix domain which reduces ability of enzyme to add non-templated 3' nucleotides to synthesized nucleic acids; genetic engineering; cloning; diagnosis; forensics; plant breeding
10/23/2001	US6306582 Mixed cell diagnostic systems
10/23/2001	US6306581 Diagnostic assay method and kit for the detection of HHV-8 infection
10/23/2001	US6306579 Immunoassay by incubating sample with at least one peptide from ns3 region having at least one covalently modified cysteine or replaced cysteine, then determining binding of antibody to peptide
10/23/2001	US6306575 Negative selection process for recovering stem cells from mixed cell sample by rection with anibodies against glycophorin a, cd3, cd24, cd16, c14, and a tumor specific antigen; removing labeled cells; and recovering preparation
10/23/2001	US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection
10/23/2001	US6306401 Genetically-engineered sindbis virus with modified E2 Glycoprotein and altered host-range phenotype
10/23/2001	US6306398 Delipidating plant powder by extraction of powder with a solution containing organic solvent; separating powder from organic solvent; extracting delipidated powder with solvent or phosphate buffered saline; separation to obtain retentate
10/23/2001	US6306388 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
10/23/2001	CA2217227C Use of a partial or complete extract of not fermented camellia sinensis l. for the preparation of a medicament, a medical care product, a cosmetic preparation or a food complementary product
10/23/2001	CA2125043C Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin
10/23/2001	CA1341308C Vaccines against avian herpes viruses
10/23/2001	CA1341307C Nucleotide sequences of avian herpes viruses
10/20/2001	CA2344770A1 Dna encoding for a disease resistance gene from common bean and methods of use
10/18/2001	WO2001077676A1 T2r taste receptors and genes encoding same
10/18/2001	WO2001077389A2 Genes expressed in foam cell differentiation
10/18/2001	WO2001077343A1 MUIR-TORRE-LIKE SYNDROME INFhit DEFICIENT MICE
10/18/2001	WO2001077342A1 Multivalent antibodies and uses therefor
10/18/2001	WO2001077340A1 Identification of a dual specificity phosphatase: dusp-10
10/18/2001	WO2001077339A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001	WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3
10/18/2001	WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077321A2 Identification of a human gaba transporter
10/18/2001	WO2001077315A1 Signal sequence trapping
10/18/2001	WO2001077312A1 A transformant for screening of inhibitors for human immunodeficiency virus
10/18/2001	WO2001077304A1 Method of producing adenoviral vector stocks
10/18/2001	WO2001077303A2 Human ovarian mesothelial cells and methods of isolation and uses thereof
10/18/2001	WO2001077302A1 Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes
10/18/2001	WO2001077301A1 Tumor cells transformation process
10/18/2001	WO2001077300A2 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
10/18/2001	WO2001077299A2 A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS
10/18/2001	WO2001077298A2 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof
10/18/2001	WO2001077181A2 Anti-rhesus d monoclonal antibodies
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077171A2 Soluble zalpha11 cytokine receptors
10/18/2001	WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077158A1 Hepatitis b core antigen fusion proteins
10/18/2001	WO2001077150A2 Serine-threonine kinase
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077148A2 Human lipid binding protein 1
10/18/2001	WO2001077147A2 New bromodomain protein
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077136A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
10/18/2001	WO2001076611A1 Method for preparing a cellular graft from fetal tissues
10/18/2001	WO2001076507A2 Use of oxygen carriers to improve grafted cell survival in neural transplantation
10/18/2001	WO2001076361A1 Animal and cell models for type ii diabetes and their use
10/18/2001	WO2001076360A2 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
10/18/2001	WO2001059450A8 Cells expressing zinc finger protein for drug discovery
10/18/2001	WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001025430A3 Novel human membrane proteins
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2001021783A3 Seed-preferred promoter from maize
10/18/2001	WO2001021780A3 Targeted gene removal
10/18/2001	WO2001020012A3 Enhanced plant cell transformation by addition of host genes involved in t-dna integration
10/18/2001	WO2001020004A3 Protein phosphatase and kinase proteins
10/18/2001	WO2001019962A3 Method of preserving tissue viability during mechanical separation process
10/18/2001	WO2000069898A8 Molecular interactions in allergy cells
10/18/2001	WO2000046236A9 Novel rgs-containing molecules and uses thereof
10/18/2001	WO2000044893A9 In vitro activated gamma delta lymphocytes
10/18/2001	WO2000043498A9 Human liver progenitors
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage

1 ... 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 ... 1827